ISSNs: 0006-4971

Additional searchable ISSN (Electronic): 1528-0020

American Society of Hematology

Scopus rating (2021): CiteScore 19.5 SJR 4.834 SNIP 3.105



  1. 2022
  2. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukaemia

    Haematological Malignancy Research Network, 30 Jun 2022, (Accepted/In press)

    Article in Blood

  3. STAT1 is essential for HSC function and maintains MHCIIhi stem cells that resists myeloablation and neoplastic expansion

    Li, J., Williams, M. J., Park, H. J., Bastos, H. P., Wang, X., Prins, D. P., Wilson, N. K., Johnson, C., Sham, K., Wantoch, M., Watcham, S., Kinston, S. J., Pask, D. C., Hamilton, T. L., Sneade, R., Waller, A. K., Ghevaert, C., Vassiliou, G. S., Laurenti, E., Kent, D. G., & 2 othersGottgens, B. & Green, A. R., 29 Jun 2022, (E-pub ahead of print)

    Article in Blood

  4. 2021
  5. HIF2α is a Direct Regulator of Neutrophil Motility

    Sormendi, S., Deygas, M., Sinha, A., Bernard, M. L. M., Krüger, A., Kourtzelis, I., Le Lay, G. M., Sáez, P. J., Gerlach, M., Franke, K., Meneses, A., Kräter, M., Palladini, A., Guck, J., Coskun, Ü., Chavakis, T., Vargas, P. & Wielockx, B., 22 Feb 2021, (E-pub ahead of print)

    Article in Blood

  6. 2020
  7. Activation of the receptor tyrosine kinase RET improves long-term hematopoietic stem cell outgrowth and potency

    Grey, W. G., Chauhan, R., Piganeau, M., Huerga Encabo, H., Garcia-Albornoz, M., McDonald, N. Q. & Bonnet, D., 26 Nov 2020

    Article in Blood

  8. Mutation Profiles Identify Distinct Clusters of Lower Risk Myelodysplastic Syndromes with Unique Clinical and Biological Features and Clinical Endpoints

    Malcovati, L., Crouch, S., De Graaf, A. O., Sandmann, S., Tobiasson, M., Kosmider, O., van der Reijden, B. A., Painter, D., Van de Loosdrecht, A. A., Symeonidis, A., Cermak, J., Clappier, E., Preudhomme, C., Stauder, R., Mittelman, M., Germing, U., Bowen, D., Fenaux, P., Van Marrewijk, C., Smith, A., & 5 othersDugas, M., Hellstrom Lindberg, E., de Witte, T. M., Fontenay, M. & Jansen, J., 5 Nov 2020

    Meeting abstract in Blood

  9. Survival Outcomes for Plasmablastic Lymphoma: An International, Multicentre Study By the Australasian Lymphoma Alliance

    Ciaccio, P. R. D., Polizzotto, M. N., Cwynarski, K., Burton, C., Jiamsakul, A., Bower, M., Kuruvilla, J., Montoto, S., McKay, P., Osborne, W., Milliken, S., Linton, K., Manos, K., Kassam, S., Doo, N. W., Watson, A-M., Fedele, P. L., Yannakou, C. K., Hunt, S., Renshaw, H., & 9 othersThakrar, N., Smith, A., Painter, D., Maxwell, A., Liu, Q., Dhairyawan, R., Ferguson, G., Pickard, K. & Hamad, N., 5 Nov 2020

    Meeting abstract in Blood

  10. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

    Lacy, S. E., Barrans, S. L., Beer, P. A., Painter, D., Smith, A. G., Roman, E., Cooke, S. L., Ruiz, C., Glover, P., Van Hoppe, S. J. L., Webster, N., Campbell, P. J., Tooze, R. M., Patmore, R., Burton, C., Crouch, S. & Hodson, D. J., 14 May 2020

    Article in Blood

  11. 2019
  12. 40% of Females with Mantle Cell Lymphoma Are Managed with Initial Observation: Results from the MCL Biobank Observational Study

    McCulloch, R., Smith, A., Wainman, B., Ingram, W., Lewis, A., Hawkins, M., Crosbie, N., Pettitt, A. & Rule, S., 13 Nov 2019

    Meeting abstract in Blood

  13. Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel

    Bewicke-Copley, F., Korfi, K., Araf, S., Kumar, E. A., Cummin, T. E. C., Ashton-Key, M., Barrans, S., Van Hoppe, S., Burton, C., Elshiekh, M., Rule, S., Crosbie, N., Clear, A. J., Calaminici, M., Scott, D. W., Rimsza, L. M., Geetha, M., Sha, C., Bentley, M. A., Nagano, A., & 10 othersDavies, A., Painter, D., Smith, A., Gribben, J. G., Naresh, K., Westhead, D. R., Okosun, J., Johnson, P., Wang, J. & Fitzgibbon, J., 13 Nov 2019

    Meeting abstract in Blood

  14. Targeted Sequencing Predicts the Development of Myeloid Malignancies and Clinical Outcome in Patients with Unexplained Cytopenia

    Cargo, C., Bolton, K., Beinortas, T., Glover, P., Short, M., Smith, A., Taylor, J., Evans, P. A. S., Papaemmanuil, E. & Crouch, S., 13 Nov 2019

    Meeting abstract in Blood

  15. An International Multicentre Study of Consecutively Diagnosed Patients with ALCL: Outcomes Following First-Line Therapy in Routine Clinical Practice

    Martinez-Calle, N., Kirkwood, A. A., Lamb, M., Smith, A., Manos, K., Shrubsole, C., Gray, N., Ladani, S., Lewis, K. L., Bishton, M., Ahearne, M. J., Hawkes, E. A., Osborne, W., Collins, G. P., Burton, C. & Fox, C. P., 1 Nov 2019

    Meeting abstract in Blood

  16. The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis

    Cargo, C., Cullen, M., Taylor, J., Short, M., Glover, P., Van Hoppe, S., Smith, A. G., Evans, P. & Crouch, S., 3 Jan 2019, (E-pub ahead of print)

    Article in Blood

  17. 2018
  18. Niche Heterogeneity Impacts Evolution of Myeloproliferative Neoplasms Driven By the Same Oncogenic Pathway

    Korn, C., Rak, J., Garcia-Garcia, A., Fielding, C., Khorshed, R., Gonzalez-Anton, S., Li, J., Norfo, R., Baxter, EJ., McKerrell, T., Roberts, T., Eldaly, H., Godfrey, AL., Castillo-Venzor, A., Kusumbe, A., Mead, AJ., Green, AR., Kent, D., Lo Celso, C. & Mendez-Ferrer, S., 29 Nov 2018

    Article in Blood

  19. Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival

    Hoeks, M., Bagguley, T., Roelofs, R., De Swart, L., Bowen, D., Symeonidis, A., van Marrewijk, C., Hellström-Lindberg, E., Tatic, A., Langemeijer, S., Culligan, D. J., Macheta, M., Garelius, H., Spanoudakis, M., Killick, S., Panagiotidis, P., Stanca Ciocan, O., Mills, J., Pottinger, B., Ackroyd, S., & 5 othersHall, C., Droste, J., Smith, A., Swinkels, D. W. & de Witte, T. M., 1 Nov 2018

    Meeting abstract in Blood

  20. Excess Mortality in Low-Risk MDS Can be Explained By MDS and AML Related Causes of Death

    Madry, K., Yu, G., Lis, K., Fenaux, P., Bowen, D., Symeonidis, A., Mittelman, M., Stauder, R., Cermak, J., Sanz, G., Hellström-Lindberg, E., Malcovati, L., Langemeijer, S., Germing, U., Skov Holm, M., Guerci-Bresler, A., Culligan, D., Sanhes, L., Mills, J., Kotsianidis, I., & 4 othersvan Marrewijk, C., Crouch, S., de Witte, T. M. & Smith, A., 1 Nov 2018

    Meeting abstract in Blood

  21. Longitudinal Changes of Impairments in Health-Related Quality of Life in Lower-Risk MDS Patients: A European Leukemianet Study

    Stauder, R., Yu, G., Koinig, K. A., Culligan, D., Fenaux, P., Cermak, J., Symeonidis, A., Bernal, T., Hellström-Lindberg, E., Mittelman, M., Langemeijer, S., Holm, M. S., Mills, J., Guerci-Bresler, A., van Marrewijk, C., Garelius, H., Efficace, F., Smith, A., Bowen, D. & de Witte, T. M., 1 Nov 2018

    Meeting abstract in Blood

  22. Single-cell approaches identify the molecular network driving malignant hematopoietic stem cell self-renewal.

    Shepherd, MS., Li, J., Wilson, NK., Oedekoven, CA., Li, J., Belmonte, M., Fink, J., Prick, JCM., Pask, DC., Hamilton, TL., Loeffler, D., Rao, A., Schröder, T., Göttgens, B., Green, AR. & Kent, DG., 23 Aug 2018

    Article in Blood

  23. A single-cell hematopoietic landscape resolves 8 lineage trajectories and defects in Kit mutant mice

    Dahlin, JS., Hamey, FK., Pijuan-Sala, B., Shepherd, M. S., Lau, WWY., Nestorowa, S., Weinreb, C., Wolock, S., Hannah, R., Diamanti, E., Kent, DG., Göttgens, B. & Wilson, NK., 24 May 2018

    Article in Blood

  24. Defining the requirements for the pathogenic interaction between mutant calreticulin and MPL in MPN

    Elf, S., Abdelfattah, N. S., Baral, A. J., Rivera, J., Chen, E. & Mullaly, A., 15 Feb 2018

    Article in Blood

  25. Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage.

    Li, J., Prins, D., Park, HJ., Grinfeld, J., Gonzalez-Arias, C., Loughran, S., Dovey, OM., Klampfl, T., Bennett, C., Hamilton, TL., Pask, DC., Sneade, R., Williams, M., Aungier, J., Ghevaert, C., Vassiliou, GS., Kent, DG. & Green, AR., 8 Feb 2018

    Article in Blood

  26. 2017
  27. Can We Diagnose MDS without Bone Marrow Examination? a Proposed EUMDS-Based Non-Invasive Diagnostic Model

    Oster, H. S., Shrkihe, B. A., Crouch, S., Smith, A., Yu, G., Carmi, G., Ben-Ezra, J., Naor, S., Fenaux, P. & Symeonidis, A., 7 Dec 2017, (E-pub ahead of print)

    Meeting abstract in Blood

  28. The Impact of Diabetes Mellitus As Comorbid Condition, in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)—a Study of the European Leukemianet-Based MDS (EUMDS) Registry

    Symeonidis, A., Yu, G., Smith, A., Fenaux, P., Mittelman, M., Stauder, R., Sanz, G., Cermak, J., Hellstrom-Lindberg, E. & Malcovati, L., 7 Dec 2017, (E-pub ahead of print)

    Meeting abstract in Blood

  29. A Prognostic Classifier Based on Early Platelet Drop in Lower-Risk MDS: a Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry

    Itzykson, R., Crouch, S., Smith, A., Symeonidis, A., Hellstrom-Lindberg, E., Sanz, G., Cermak, J., Stauder, R., Malcovati, L., Germing, U., Mittelman, M., Langemeijer, S., Madry, K., Tatic, A., Holm, M. S., Almeida, A. M. D., Savic, A., Gredelj-Šimec, N., Luño Fernandez, E., Culligan, D., & 5 othersGuerci Bresler, A., van Marrewijk, C., Bowen, D. T., de Witte, T. M. M. & Fenaux, P., 1 Dec 2017

    Meeting abstract in Blood

Previous 1 2 3 4 Next

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations